ANTXR1 and cancer: The balance time of interactions between tumor cells and TEM8 antibodies was about 20 min and the minimum concentration of specific polypeptide that could be identified by tumor cells is 1 μg/mL, indicating that TEM8 was a promising target for anti-angiogenesis based anti-cancer drug development.